Answers are grounded in this paper and cite their sources.
Management of the complex anal fistula represents a perennial challenge to surgeons. Conventional approaches often upset the balance between recurrence prevention and continence preservation with their high failure rates and significant associated morbidity. The emergence of minimally invasive treatment in recent years, however, offers a promising paradigm shift. Regenerative solutions like autologous stem cell therapy or fistula plugs with extracellular and synthetic matrices represent new frontiers in anal fistula treatment, harnessing physiological regenerative capacities and avoiding the traditional postoperative burden of open wounds, drains, or setons in situ . Together with novel techniques like fistula laser closure, video-assisted fistula treatment, or over-the-scope clip burgeoning over the last decade, these state-of-the-art approaches have been touted for their total sphincter-sparing nature, preserving functional outcomes and quality of life. Despite gaining much scientific and clinical momentum, do these newer modalities live up to their promise? This review aims to critically appraise the latest evidence surrounding minimally invasive approaches, providing up-to-date insights into the constantly evolving landscape of anal fistula management. Further long-term and comparative studies will nevertheless be needed to supplement the significantly heterogenous, retrospective analyses consolidated.
No takes yet. Share an insight, caveat, or question.
Daniel Jin Keat Lee (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: